Paul C Grimm

University Of California San Diego

$31,454

Attributed

$31,454

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $7.3K · FY2005–06

$10K$7.5K$5K$2.5K$0

'05

'06

Funding mix

By agency

NIH$31,454 · 2

By mechanism

M01$31,454 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of California San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchKidney TransplantationHuman SubjectSirolimusOutcomes ResearchTransplant RejectionHuman Therapy EvaluationDisease /Therapy DurationDrug Screening /EvaluationDrug WithdrawalGenotypeHormone TherapyKidney FunctionLongitudinal Human StudyPediatric PharmacologyPediatricsPrognosisQuality Of LifeSteroid HormoneAdolescence (12-20)UrinalysisArtificial ImmunosuppressionBiopsyBlood Tests

Grant awards (5)

SIROLIMUS VS STANDARD TREATMENT IN HIGH RISK PEDIATRIC RENAL TRANSPLANT$525

M01 · FY2006 · RR · contact PI

SIROLIMUS VS STANDARD TREATMENT IN HIGH RISK PEDIATRIC RENAL TRANSPLANT$3,663

M01 · FY2005 · RR

STEROID WITHDRAWAL IN SIROLIMUS AND CYCLOSPORINE TREATED TRANSPLANT PATIENTS$3,663

M01 · FY2005 · RR

Sirolimus/Standard Therapy in Pediatric Renal Transplant$12,981

M01 · FY2004 · RR

Steroid Withdrawal--Sirolimus/Cyclosporine Transplant Pt$10,622

M01 · FY2004 · RR